Interferon type III
Interferon type III is a class of interferons, which are a group of signaling proteins made and released by host cells in response to the presence of several pathogens, such as viruses, bacteria, parasites, and tumor cells. Interferons belong to the larger class of proteins known as cytokines, which are crucial in the immune response.
Types of Interferons[edit | edit source]
Interferons are categorized into three main types: Interferon type I, Interferon type II, and Interferon type III. Each type has distinct functions and mechanisms of action.
Discovery and Structure[edit | edit source]
Interferon type III, also known as lambda interferons, includes IFN-λ1, IFN-λ2, IFN-λ3, and IFN-λ4. These interferons were discovered more recently compared to type I and type II interferons. They are structurally similar to interleukins and signal through a receptor complex composed of IL10RB and IFNLR1.
Function[edit | edit source]
Interferon type III plays a critical role in the innate immune response to viral infections. They are particularly important in the defense of epithelial surfaces, such as those found in the respiratory tract, gastrointestinal tract, and liver. Upon binding to their receptors, type III interferons activate the JAK-STAT signaling pathway, leading to the expression of interferon-stimulated genes (ISGs) that inhibit viral replication and modulate the immune response.
Clinical Significance[edit | edit source]
Interferon type III has been studied for its potential therapeutic applications in treating viral infections such as hepatitis C and COVID-19. Due to their localized action and reduced systemic side effects compared to type I interferons, they are considered promising candidates for antiviral therapies.
Research and Development[edit | edit source]
Ongoing research is focused on understanding the precise mechanisms of action of interferon type III and its potential applications in immunotherapy and antiviral treatments. Studies are also exploring the role of genetic variations in the IFN-λ genes and their impact on susceptibility to infections and response to treatments.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
